Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
|Slideshows|June 20, 2018
- Vol 28 No 6
- Volume 28
- Issue 6
Managed Care Pharmacy Survey 2018
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
Advertisement
Articles in this issue
over 8 years ago
Top Autoimmune Disease Treatment Developments to Watchover 8 years ago
Three Pharmacy Regulations Health Execs Should Watchover 8 years ago
How to Rein in Skyrocketing Orphan Drug Costsover 8 years ago
Right to Try Pros and Consover 8 years ago
Managed Care Pharmacy’s Future: What Health Execs Should Knowover 8 years ago
Pharma Pipeline Report: 7 Drugs Health Execs Should Watchover 8 years ago
How Payers are Responding to Growing Orphan Drug Costsover 8 years ago
Top Cost Considerations for CAR-T, CRISPR Cancer Treatmentover 8 years ago
Four Ways to Spur Innovation at Your Managed Care OrganizationAdvertisement
Related to this article
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Managed care leaders should vet AI tools before use and recheck them over time, and pharmacists need AI literacy, according to two AMCP Nexus 2026 presenters.
AI is speeding up managed care pharmacy work, but two pharmacists say human review remains key when tools affect patients' access to medications.
A review of 16 studies linked presurgical melatonin and zolpidem to less postoperative pain, with over 30% less opioid use in some patients.
Prime Therapeutics' Pat Gleason, Pharm.D., outlined T1D screening gaps for plans and his priorities as incoming AMCP president.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Updated HIV treatment guidelines address payer barriers and add Bixlenvo
2
5 things you should know about the midterms and healthcare
3
What stands in the way of patients with atopic dermatitis getting prescription medication? Here are some possibilities
4
Narcolepsy type 1 drives 5-fold higher costs in first year after diagnosis
5